Tuesday, 27 November 2018

NHS to save £300m on cost of most expensive drug

NHS to save £300m on cost of most expensive drug The NHS is set to save a record £300m after negotiating deals with five manufacturers on low-cost versions of the health service’s most costly drug.

The saving – the biggest in NHS history from a single drug negotiation – could pay for 11,700 more community nurses or 19,800 more breast cancer treatments for patients.

The deal has come about through the introduction of “biosimilar” versions of adalimumab, which is prescribed to more than 46,000 patients for hospital-treated, serious conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. The Independent

No comments:

Post a Comment